KIEV, April 7 – The United Nations Development Program (UNDP) has signed procurement contracts with five companies to supply 15 pediatric hemophilia medicines worth $6.955 million (logistics expenses and UNDP fee inclusive).

Patients of Ukraine reported that pursuant to the documents published by the UNDP, three Ukrainian intermediary companies Link-Medital LLC, Liudmyla-Pharm LLC and Kiev Regional Pharmaceutical Enterprise LLC and two foreign companies Novo Nordisk from Denmark and Magnipharma Ltd from Latvia won the tender.